JENNIFER TABOR-CURTIS: Open Payments
NPI 1982856472 · MOUNT STERLING, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 16 payments from 13 companies in 2025. Trend: 2023 $234 · 2024 $334 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| ABBVIE INC. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $16 |
| Indivior Inc. | 1 | $16 |
| Corium, LLC | 1 | $15 |
Products named: CAPLYTA, Auvelity, ARISTADA, MAVYRET, FARXIGA, SPRAVATO, ZURZUVAE, SUBLOCADE.
Industry payments across KY — which companies pay providers there.
